Therapy of experimental influenza virus infection with pyrrolidine dithiocarbamate

Pre-Clinical Safety Evaluation of Pyrrolidine Dithiocarbamate

(2010) Monika Chabicovsky et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Influenza Virus Evolution, Host Adaptation, and Pandemic Formation

(2010) Jeffery K. Taubenberger et al.   Cell Host & Microbe

The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analyis

(2010) Sally Eyers et al.   JOURNAL OF THE ROYAL SOCIETY OF MEDICINE

Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages

(2010) Martin Michaelis et al.   MEDICAL MICROBIOLOGY AND IMMUNOLOGY

N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus

(2009) Janina Geiler et al.   BIOCHEMICAL PHARMACOLOGY

Salicylates and Pandemic Influenza Mortality, 1918–1919 Pharmacology, Pathology, and Historic Evidence

(2009) Karen M. Starko   CLINICAL INFECTIOUS DISEASES

Therapeutic Effect of Recombinant Human Catalase on H1N1 Influenza-induced Pneumonia in Mice

(2009) Xun-long Shi et al.   INFLAMMATION

Essential Impact of NF- B Signaling on the H5N1 Influenza A Virus-Induced Transcriptome

(2009) M. Schmolke et al.   JOURNAL OF IMMUNOLOGY

Emerging antiviral targets for influenza A virus

(2009) Robert M. Krug et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008

(2008) T. G. Sheu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antibacterial activity of pyrrolidine dithiocarbamate

(2008) Mi-Sun Kang et al.   FEMS MICROBIOLOGY LETTERS

Future Target Molecules for Influenza Treatment

(2008) N. Uchide et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY